We analyzed the changes in gene expression between the Normal/NAFLD group and the NASH group then compared those to the SRSF3-dependent gene expression changes from the ENCODE dataset in HepG2 cells (Table S16). The gene discussed is SRSF3; the disease is metabolic dysfunction-associated steatotic liver disease.